Stiff person syndrome

Practical Neurology

Volumn 11, Issue 5, 2011, Pages 272-282

  Hadavi, Shahrzad ^a   Noyce, Alastair J ^a   David Leslie, R ^a   Giovannoni, Gavin ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GABAERGIC RECEPTOR AFFECTING AGENT; GLUTAMATE DECARBOXYLASE;

DIFFERENTIAL DIAGNOSIS; HISTORY; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; PHYSIOLOGY; REVIEW; STIFF MAN SYNDROME;

DIAGNOSIS, DIFFERENTIAL; GABA AGENTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HISTORY, 20TH CENTURY; HUMANS; IMMUNOMODULATION; STIFF-PERSON SYNDROME;

EID: 80052825511     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/practneurol-2011-000071     Document Type: Review

References (40)

1. Dalakas MC. Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr Treat Options Neurol 2009;11:102-10.
2. Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity and spasm ("stiff-man" syndrome); report of a case and some observations in 13 other cases. Proc Staff Meet Mayo Clin 1956;31:421-7.
3. Gordon EE, Januszko DM, Kaufman L. A critical survey of stiff-man syndrome. Am J Med 1967;42:582-99.
4. Lorish TR, Thorsteinsson G, Howard FM Jr. Stiff-man syndrome updated. Mayo Clin Proc 1989;64:629-36.
5. Solimena M, Folli F, Denis-Donini S, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 1988;318:1012-20.
6. Howard FM Jr. A new and effective drug in the treatment of the stiff-man syndrome: preliminary report. Proc Staff Meet Mayo Clin 1963;38:203-12.
7. Piccolo G, Cosi V, Zandrini C, et al. Steroid-responsive and dependent stiff-man syndrome: a clinical and electrophysiological study of two cases. Ital J Neurol Sci 1988;9:559-66.
8. Vicari AM, Folli F, Pozza G, et al. Plasmapheresis in the treatment of stiff-man syndrome. N Engl J Med 1989;320:1499.
9. Amato AA, Cornman EW, Kissel JT. Treatment of stiff-man syndrome with intravenous immunoglobulin. Neurology 1994;44:1652-4.
10. Raju R, Rakocevic G, Chen Z, et al. Autoimmunity to GABA-Areceptor- associated protein in stiff-person syndrome. Brain 2006;129:3270-6.
11. Folli F, Solimena M, Cofiell R, et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N Engl J Med 1993;328:546-51.
12. Butler MH, Hayashi A, Ohkoshi N, et al. Autoimmunity to gephyrin in Stiff-Man syndrome. Neuron 2000;26:307-12.
13. Levy LM, Dalakas MC, Floeter MK. The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid. Ann Intern Med 1999;131:522-30.
14. Thompson PD. The stiff-man syndrome and related disorders. Parkinsonism Relat Disord 2001;8:147-53.
15. Nollet H, Vanderstraeten G, Sustronck B, et al. Suspected case of stiff-horse syndrome. Vet Rec 2000;146:282-4.
16. Solimena M, Folli F, Aparisi R, et al. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990;322:1555-60.
17. Lohmann T, Hawa M, Leslie RD, et al. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. Lancet 2000;356:31-5.
18. Ellis TM, Atkinson MA. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nat Med 1996;2:148-53.
19. Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New York, NY: Garland Science Publishing Company 2001:711-26.
20. Dalakas MC, Fujii M, Li M, et al. The clinical spectrum of anti- GAD antibody-positive patients with stiff-person syndrome. Neurology 2000;55:1531-5.
21. Gershanik OS. Stiff-person syndrome. Parkinsonism Relat Disord 2009;15(Suppl 3):S130-4.
22. Meinck HM. Stiff man syndrome. CNS Drugs 2001; 15:515-26.
23. Ameli R, Snow J, Rakocevic G, et al. A neuropsychological assessment of phobias in patients with stiff person syndrome. Neurology 2005;64:1961-3.
24. Gerschlager W, Schrag A, Brown P. Quality of life in stiff-person syndrome. Mov Disord 2002;17:1064-7.
25. Ruivard M, Berger C, Achaibi A, et al. Physician compliance with outpatient oral anticoagulant guidelines in Auvergne, France. J Gen Intern Med 2003;18:903-7.
26. Economides JR, Horton JC. Eye movement abnormalities in stiff person syndrome. Neurology 2005;65:1462-4.
27. Barker RA, Revesz T, Thom M, et al. Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatr 1998;65:633-40.
28. Leslie RD. Predicting adult-onset autoimmune diabetes: clarity from complexity. Diabetes 2010;59:330-1.
29. Brown P, Marsden CD. The stiff man and stiff man plus syndromes. J Neurol 1999;246:648-52.
30. Gouider-Khouja N, Mekaouar A, Larnaout A, et al. Progressive encephalomyelitis with rigidity presenting as a stiff-person syndrome. Parkinsonism Relat Disord 2002;8:285-8.
31. McCombe PA, Chalk JB, Searle JW, et al. Progressive encephalomyelitis with rigidity: a case report with magnetic resonance imaging findings. J Neurol Neurosurg Psychiatr 1989;52:1429-31.
32. Stayer C, Tronnier V, Dressnandt J, et al. Intrathecal baclofen therapy for stiff-man syndrome and progressive encephalomyelopathy with rigidity and myoclonus. Neurology 1997;49:1591-7.
33. Silbert PL, Matsumoto JY, McManis PG, et al. Intrathecal baclofen therapy in stiff-man syndrome: a double-blind, placebo-controlled trial. Neurology 1995;45:1893-7.
34. Meinck HM, Tronnier V, Rieke K, et al. Intrathecal baclofen treatment for stiff-man syndrome: pump failure may be fatal. Neurology 1994;44:2209-10.
35. Bardutzky J, Tronnier V, Schwab S, et al. Intrathecal baclofen for stiff-person syndrome: life-threatening intermittent catheter leakage. Neurology 2003;60:1976-8.
36. Sechi G, Barrocu M, Piluzza MG, et al. Levetiracetam in stiffperson syndrome. J Neurol 2008;255:1721-5.
37. Dalakas MC, Fujii M, Li M, et al. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 2001;345:1870-6.
38. Elovaara I, Apostolski S, van Doorn P, et al. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol 2008;15:893-908.
39. Baker MR, Das M, Isaacs J, et al. Treatment of stiff person syndrome with rituximab. J Neurol Neurosurg Psychiatr 2005;76:999-1001.
40. Mitsumoto H, Schwartzman MJ, Estes ML, et al. Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome. J Neurol 1991;238:91-6.